MDT perspectives on minimizing TKI-associated toxicities in patients with CML

from touchPODCAST · host touchpodcast

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team explore how to minimize toxicities while maximizing treatment benefit for patients with chronic myeloid leukaemia The multidisciplinary team Nurse specialist: Johan De Munter, Belgium Haematologist: Prof. Dr med. Andreas Hochhaus, Germany This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME. For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/

Episode metadata supplied by the publisher feed · Published May 9, 2022

Embed this episode

Attribution link and audio player

Ready to play

MDT perspectives on minimizing TKI-associated toxicities in patients with CML

0:00 13:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 13 minutes long.

When was this touchPODCAST episode published?

This episode was published on May 9, 2022.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!